UK: 10 Things You Need To Know About The European Market Infrastructure Regulation

Last Updated: 18 September 2013
Article by Adrian Brown and Sam Robinson

Summary and implications

We have been talking about the European Market Infrastructure Regulation (EMIR) for years. With certain parts of EMIR now in force and others planned imminently, here are 10 key questions to help you understand if, and how, you will be affected by EMIR.

1. Should I care about EMIR?

Generally, if you are based in the European Economic Area and trade in derivatives, whether on-exchange or "over-the-counter" (OTC), then you will be impacted by EMIR. This could include real estate investors who use derivatives and swaps (e.g. hedging interest rate and currency risks) to reduce risk rather than for speculative purposes. The exact impact of EMIR will depend on the type of firm, as well as the level and type of derivative exposure of the particular firm.

2. What are the requirements under EMIR?

In summary, EMIR brings in new requirements relating to:

  • authorisation and supervision of central counterparties (CCPs) and trade repositories (TRs);
  • reporting trade details of all derivative trades (not just OTC) to TRs;
  • clearing "eligible" OTC derivatives through a CCP; and
  • when OTC derivatives are not centrally cleared, firms will need to implement alternative risk mitigation techniques.

While only a handful of firms are expected to become CCPs or TRs, other firms will need to consider how to comply with the requirements relating to clearing and trade reporting.

3. How do I satisfy the reporting requirement?

EMIR requires certain details of all derivatives (both OTC and on-exchange) to be reported to a TR by both counterparties.

From a practical perspective, once a TR has been registered to receive reporting information in relation to the type of derivative concerned, a firm must either:

1. enter into direct arrangements with a TR; or

2. delegate reporting arrangements to a third party (such as a broker, CCP or trading platform), which would in turn have an arrangement with a TR.

4. How will clearing work?

The European Securities and Markets Authority (ESMA), along with national regulators, will determine which "standard" OTC derivatives should be cleared through a CCP. They will take into account criteria including whether the derivatives have common legal documentation, volume, liquidity and the availability of fair, reliable and generally accepted pricing information. In July 2013 ESMA published a discussion paper outlining this procedure in further detail. When these derivatives have been determined and CCPs have been authorised, firms will then need to enter into either direct or indirect clearing arrangements with a CCP to clear these derivatives.

5. What about trades that are not centrally cleared?

OTC derivatives that are not cleared through a CCP can continue to be traded directly between counterparties. However, firms will need to comply with alternative risk mitigation techniques when entering into these types of OTC derivative contracts.

6. I've heard that EMIR applies differently to "financial counterparties" and "non-financial counterparties", is this correct?

This distinction is relevant in relation to the clearing and risk mitigation obligations. It does not make any difference to the trade reporting obligation.

The requirement to clear certain OTC derivatives through a CCP applies automatically to financial counterparties. However, this only applies to non-financial counterparties when they have exposure to OTC derivatives above a certain level, referred to as being a "NFC+".

In relation to the risk mitigation techniques, non-financial counterparties that do not exceed this level, referred to as being "NFC-", will only have to comply with some of the risk mitigation requirements (not all of them). Firms will need to consider whether they are a financial counterparty or a non-financial counterparty, and whether they are an NFC+ or NFC-, in relation to which clearing and risk mitigation obligations apply to them.

7. What are the thresholds between an NFC+ and an NFC-?

Non-financial counterparties will need to consider whether they have exposure to OTC derivatives above the thresholds in the table opposite. When making this calculation, firms are not required to take into account any OTC derivatives that they enter into for hedging purposes. But they must include all OTC derivatives entered into by non-financial counterparties within their group on a global basis. If a non-financial counterparty exceeds the clearing threshold they must notify the Financial Conduct Authority and ESMA.

8. What will firms need to do to satisfy the collateral requirement?

One of the risk mitigation requirements for OTC derivatives that are not cleared through a CCP relates to the exchange of collateral. While there has been much debate at international level, earlier this month the International Organisation of Securities Commissions and the Basel Committee on Banking Supervision published the final framework relating to the exchange of collateral. This confirmed, amongst other things, that parties will be required to exchange both initial and variation margin. These requirements will be implemented in the EU through new binding technical standards which will be consulted on by the European Banking Authority (co-operating with the other European regulators) in due course.

Impact on real estate

For a real estate sector business which is caught by EMIR:

  • standardised swap activities (determined by ESMA) may need to be cleared through CCPs, with appropriate liquid collateral (real estate does not currently count) and reporting; and
  • for swaps that are not cleared through a CCP, it will have to have risk management procedures in place, potentially including the marking-to-market of outstanding contracts on a daily basis.

9. What is the timing of EMIR?

EMIR enters into force on a staged basis. One of the risk mitigation techniques, relating to timely confirmation, entered into force on 15 March 2013. The risk mitigation techniques of portfolio reconciliation, portfolio compression and dispute resolution are scheduled to enter into force on 15 September 2013. The risk mitigation technique relating to the exchange of collateral is not expected to enter into force until 2014 or 2015.

The reporting obligation for credit and interest rate derivatives was scheduled to begin in September 2013, but ESMA recently announced that this has been delayed until 1 January 2014. This is the date from which the reporting obligations relating to the other types of derivatives should also apply. However, this date is dependent on the registration of a TR to accept the relevant trade reports.

With no CCPs having yet been authorised, the clearing obligation is not expected to come into force until 2014 or 2015.

10.How does EMIR fit in with the Alternative Investment Fund Managers Directive (AIFMD)?

EMIR applies differently depending on whether the relevant fund, or structuring entity that enters into OTC derivatives, is classified as an "alternative investment fund" (AIF) under the AIFMD.

AIFs fall within the definition of a financial counterparty. As mentioned above in question 6, this means that the full clearing and risk mitigation obligations would apply when an AIF enters into OTC derivatives (even for hedging purposes).

One important area is who is a "financial counterparty" and therefore within the scope of the more detailed requirements of EMIR. This includes AIFs under AIFMD, as well as banks and other financial institutions

However, any entity in a fund structure that is not an AIF will instead be classified as a non-financial counterparty (including a fund before it is classified as an AIF under the AIFMD). Where these entities enter into OTC derivatives, they will not need to comply with the full clearing and risk mitigation requirements unless they enter into OTC derivatives with a value above the relevant clearing threshold and become an NFC+. As mentioned in question 7, any calculation relating to whether a non-financial counterparty exceeds the clearing threshold would not take into account any OTC derivatives that have been entered into for hedging purposes.

This article was previously published by Compliance Complete by Thomson Reuters Accelus

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.